HomeEXECUTIVESNovApproach Spine Elects Sigurd H. Berven, MD, to Board

NovApproach Spine Elects Sigurd H. Berven, MD, to Board

NovApproach Spine, developer of the patented OneLIF™ interbody spinal fusion system, which supports a multitude of surgical approaches, announced today the election of orthopaedic surgeon Sigurd Berven, MD, to its board of managers. Berven is the chief of spine service and professor of orthopedic surgery at the University of California, San Francisco (UCSF). A member of NovApproach’s OneLIF design team, Berven was the first to use the implant in spine surgery.

NovApproach CEO Raymond Cloutier reports, “Dr. Berven has been a chief contributor to the OneLIF cage’s evolution. A world-renowned expert in treating spinal disorders, he brings clinical, research and academic perspectives that will strengthen our company’s ability to deliver clinically relevant solutions. It’s an honor to have his guidance during our company’s rapid growth.”

According to Berven, “It’s been truly rewarding to collaborate with the OneLIF design team. Since performing the first surgery with this versatile cage, I found its unique versatility particularly helpful for patients with both standard and challenging anatomic conditions. I’m proud to join NovApproach’s board as we expand adoption of OneLIF to benefit many surgeons and their patients.”

The OneLIF system offers surgeons a groundbreaking solution: a single cage that supports three distinct approaches to the patient’s lumbar spine: Anterior Lumbar Interbody Fusion (ALIF), the LateralATP™ Approach and the SupineATP® Approach. This enables surgeons to optimize their approach while the OneLIF cage’s six fixation screw options and two inserter positions offer unprecedented flexibility to address varying patient anatomies.

Dr. Berven’s journey is marked by academic excellence, including completing his studies at Stanford University and Oxford University, earning his medical degree from Harvard Medical School, and completing a spine surgery fellowship at UCSF. He is widely recognized for his expertise and frequently speaks at national and international conferences on advanced techniques in spinal surgery. Dr. Berven will share his experience with OneLIF during scheduled times at NovApproach’s educational exhibit #2507 at the 2023 North American Spine Society Annual Meeting, Oct. 18 – 21 in Los Angeles.

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


Dr Charles R Gordon was the founding Chairman of the Board for Baylor Scott & White's Texas Spine & Joint Hospital. Over the years the hospital has grown, and majority interest of the hospital was sold to Baylor Scott & White and United Surgical Partners International (USPI).
"We are excited to welcome Jeff Anderson to Nutjobs as our new CEO. His broad experience and tactical leadership will be instrumental in executing against our vision to provide innovative, sustainable solutions to our customers," said Paul Kephart, Co-Founder, Chief Technology Officer and Chairperson of the Nutjobs Board.
Potrero Medical believes that this voluntary reorganization will bolster its finances and facilitate its ongoing focus on elevating patient care.
Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.

By using this website you agree to accept Medical Device News Magazine Privacy Policy